This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Methylphenidate-Induced Akathisia in a Patient With Multiple Sclerosis

Maria S. Almeida, MD; Prasad R. Padala, MD; Subhash Bhatia, MD

Published: December 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Methylphenidate is a short-acting psychostimulant thatis structurally and pharmacologically similar to dextroamphetamineand is primarily used in the treatment of attention-deficit/hyperactivity disorder (ADHD).1,2 Its use has also been exploredfor the treatment of apathy and for augmentation ofeffects of antidepressants.3 It acts as a dopaminergic and noradrenergicreuptake inhibitor.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 8

Quick Links: Multiple Sclerosis , Neurologic and Neurocognitive


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...